CDD3505
CAS No. 173865-33-3
CDD3505( 4-nitro-1-trityl-1H-imidazole )
Catalog No. M26553 CAS No. 173865-33-3
CDD3505 increases high-density lipoprotein cholesterol by targeting hepatic CYP3A.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 80 | Get Quote |
|
| 10MG | 140 | Get Quote |
|
| 25MG | 254 | Get Quote |
|
| 50MG | 377 | Get Quote |
|
| 100MG | 537 | Get Quote |
|
| 500MG | 1152 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCDD3505
-
NoteResearch use only, not for human use.
-
Brief DescriptionCDD3505 increases high-density lipoprotein cholesterol by targeting hepatic CYP3A.
-
DescriptionCDD3505 increases high-density lipoprotein cholesterol by targeting hepatic CYP3A.
-
In VitroCDD3505 specifically induces hepatic cytochrome P450IIIA produces significant increases in HDL cholesterol.
-
In Vivo——
-
Synonyms4-nitro-1-trityl-1H-imidazole
-
PathwayMetabolic Enzyme/Protease
-
TargetP450
-
RecptorAnti-infection| Bacterial| HIV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number173865-33-3
-
Formula Weight355.397
-
Molecular FormulaC22H17N3O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 14.29 mg/mL (40.21 mM)
-
SMILES[O-][N+](=O)c1cn(cn1)C(c1ccccc1)(c1ccccc1)c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Chaudhuri S, et al. Binding of the bioflavonoid robinetin with model membranes and hemoglobin: Inhibition of lipid peroxidation and protein glycosylation. J Photochem Photobiol B. 2010 Jan 21;98(1):12-9.
molnova catalog
related products
-
Bergapten
5-Methoxypsoralen, a naturally occurring linear furocoumarin, has been successfully used in combination with ultraviolet (UV) A irradiation [psoralen plus UV (PUVA)] to manage psoriasis and vitiligo.
-
N-desmethyl Olanzapi...
N-desmethyl Olanzapine is a metabolite of the atypical antipsychotic compound Olanzapinec, which is formed through the oxidative metabolism of olanzapine by the cytochrome 450 (CYP) isoenzyme CYP1A2.
-
JNJ0966
JNJ0966 is a highly selective MMP-9 zymogen inhibitor (IC50: 440 nM).
Cart
sales@molnova.com